Predicted Trait | |
Reported Trait | Prostate cancer |
Mapped Trait(s) | prostate carcinoma (EFO_0001663) |
Score Construction | |
PGS Name | prscs.auto.GCST006085.Prostate_cancer |
Development Method | |
Name | PRS-CS-auto |
Parameters | phi:auto |
Variants | |
Original Genome Build | GRCh38 |
Number of Variants | 1,105,199 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000517 |
Citation (link to publication) | Monti R et al. Am J Hum Genet (2024) |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST006085 Europe PMC: 29892016 |
140,254 individuals | European | NR |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
— | 9,671 individuals, 100.0 % Male samples |
European | UKB | — | — | — | — | — |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM019569 | PSS011221| European Ancestry| 68,516 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 1.80595 [1.73048314, 1.8847033] β: 0.59109 [0.54840064, 0.63377041] |
AUROC: 0.6624 [0.65109537, 0.67370194] | R²: 0.07916 [0.06887128, 0.08999476] | 0 | beta = log(or)/sd_pgs |
PPM019570 | PSS011232| European Ancestry| 171,474 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 2.05454 [2.01691586, 2.09287461] β: 0.72005 [0.70156954, 0.73853853] |
AUROC: 0.69351 [0.6889787, 0.69804346] | R²: 0.11337 [0.10797044, 0.11887705] | 0 | beta = log(or)/sd_pgs |
PPM019571 | PSS011245| South Asian Ancestry| 19,738 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 2.12708 [1.74969815, 2.58584538] β: 0.75475 [0.55944329, 0.95005249] |
AUROC: 0.70896 [0.65720843, 0.76072108] | R²: 0.08902 [0.04599459, 0.13892936] | 0 | beta = log(or)/sd_pgs |
PPM019572 | PSS011261| European Ancestry| 31,410 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 1.87036 [1.78869769, 1.9557568] β: 0.62613 [0.58148781, 0.67077723] |
AUROC: 0.6708 [0.65946402, 0.6821401] | R²: 0.08647 [0.07503424, 0.09847291] | 0 | beta = log(or)/sd_pgs |
PPM019573 | PSS011289| South Asian Ancestry| 4,976 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 2.10264 [1.75170999, 2.52386924] β: 0.74319 [0.56059245, 0.92579314] |
AUROC: 0.70361 [0.65513648, 0.75208618] | R²: 0.08919 [0.05003056, 0.14377367] | 0 | beta = log(or)/sd_pgs |
PPM019574 | PSS011274| European Ancestry| 41,305 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 1.9751 [1.89295623, 2.06080819] β: 0.68062 [0.63813975, 0.72309823] |
AUROC: 0.68255 [0.67175657, 0.6933417] | R²: 0.10323 [0.09195074, 0.11628312] | 0 | beta = log(or)/sd_pgs |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS011274 | — | — | [ ,
100.0 % Male samples |
— | European | — | UKB | — |
PSS011245 | — | — | [ ,
100.0 % Male samples |
— | South Asian | — | G&H | — |
PSS011221 | — | — | [ ,
100.0 % Male samples |
— | European | — | EB | — |
PSS011289 | — | — | [ ,
100.0 % Male samples |
— | South Asian | — | UKB | — |
PSS011261 | — | — | [ ,
100.0 % Male samples |
— | European | — | HUNT | — |
PSS011232 | C3_PROSTATE, ICD10: C61, ICD9: 185 | — | [ ,
100.0 % Male samples |
— | European | — | FinnGen | — |